Found: 7
Select item for more details and to access through your institution.
Does low-dose prolonged steroid therapy affect the natural history of chronic hepatitis C?
- Published in:
- Journal of Medical Virology, 2014, v. 86, n. 5, p. 758, doi. 10.1002/jmv.23889
- By:
- Publication type:
- Article
TRPM5 rs886277 Polymorphism Predicts Hepatic Fibrosis Progression in Non-Cirrhotic HCV-Infected Patients.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 3, p. 483, doi. 10.3390/jcm10030483
- By:
- Publication type:
- Article
The Myeloid-Epithelial-Reproductive Tyrosine Kinase (MERTK) rs4374383 Polymorphism Predicts Progression of Liver Fibrosis in Hepatitis C Virus-Infected Patients: A Longitudinal Study.
- Published in:
- Journal of Clinical Medicine, 2018, v. 7, n. 12, p. 473, doi. 10.3390/jcm7120473
- By:
- Publication type:
- Article
CXCL9‐11 polymorphisms are associated with liver fibrosis in patients with chronic hepatitis C: a cross‐sectional study.
- Published in:
- Clinical & Translational Medicine, 2017, v. 6, n. 1, p. 1, doi. 10.1186/s40169-017-0156-3
- By:
- Publication type:
- Article
Profiles and clinical management of hepatitis C patients in Spain: disHCovery study.
- Published in:
- Revista Española de Quimioterapia, 2015, v. 28, n. 3, p. 145
- By:
- Publication type:
- Article
Impact of DARC rs12075 Variants on Liver Fibrosis Progression in Patients with Chronic Hepatitis C: A Retrospective Study.
- Published in:
- Biomolecules (2218-273X), 2019, v. 9, n. 4, p. 143, doi. 10.3390/biom9040143
- By:
- Publication type:
- Article
The IL7RA rs6897932 polymorphism is associated with progression of liver fibrosis in patients with chronic hepatitis C: Repeated measurements design.
- Published in:
- PLoS ONE, 2018, v. 13, n. 5, p. 1, doi. 10.1371/journal.pone.0197115
- By:
- Publication type:
- Article